CIK 0001526119 · Non-accelerated filer<br>Smaller reporting company
Verastem, Inc.
Sign in to watch- Ticker
- VSTM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- operating
- EIN
- 273269467
- Phone
- (781) 292-4200
- Business address
- 117 KENDRICK STREET, SUITE 500, NEEDHAM, MA, 02494
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $386,390
- in 4 filings, $386K under 10b5-1 plans
Net −$386,390. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-11 | Paterson Dan President and CEO | Returned to the company · Stock Option (right to buy) | −16,666 | 0 | ||
| 2024-03-11 | Paterson Dan President and CEO | Returned to the company · Stock Option (right to buy) | −12,500 | 0 | ||
| 2024-03-11 | Paterson Dan President and CEO | Returned to the company · Stock Option (right to buy) | −33,962 | 0 | ||
| 2024-03-11 | Paterson Dan President and CEO | Returned to the company · Stock Option (right to buy) | −30,708 | 0 | ||
| 2024-03-11 | Paterson Dan President and CEO | Grant or award · Stock Option (right to buy) | +144,137 | 144,137 | ||
| 2024-03-11 | Paterson Dan President and CEO | Grant or award · Stock Option (right to buy) | +23,843 | 23,843 | ||
| 2024-03-11 | Calkins Daniel Chief Financial Officer | Returned to the company · Stock Option (right to buy) | −631 | 0 | ||
| 2024-03-11 | Calkins Daniel Chief Financial Officer | Returned to the company · Stock Option (right to buy) | −833 | 0 | ||
| 2024-03-11 | Calkins Daniel Chief Financial Officer | Returned to the company · Stock Option (right to buy) | −1,666 | 0 | ||
| 2024-03-11 | Calkins Daniel Chief Financial Officer | Returned to the company · Stock Option (right to buy) | −833 | 0 | ||
| 2024-03-11 | Calkins Daniel Chief Financial Officer | Returned to the company · Stock Option (right to buy) | −750 | 0 | ||
| 2024-03-11 | Calkins Daniel Chief Financial Officer | Returned to the company · Stock Option (right to buy) | −1,875 | 0 | ||
| 2024-03-11 | Calkins Daniel Chief Financial Officer | Grant or award · Stock Option (right to buy) | +5,413 | 5,413 | ||
| 2024-03-11 | Calkins Daniel Chief Financial Officer | Grant or award · Stock Option (right to buy) | +1,175 | 1,175 | ||
| 2024-03-11 | ROBERTSON MICHELLE Director | Returned to the company · Stock Option (right to buy) | −5,291 | 0 | ||
| 2024-03-11 | ROBERTSON MICHELLE Director | Grant or award · Stock Option (right to buy) | +5,291 | 5,291 | ||
| 2024-03-11 | Kauffman Michael Director | Returned to the company · Stock Option (right to buy) | −2,083 | 0 | ||
| 2024-03-11 | Kauffman Michael Director | Returned to the company · Stock Option (right to buy) | −1,497 | 0 | ||
| 2024-03-11 | Kauffman Michael Director | Returned to the company · Stock Option (right to buy) | −2,083 | 0 | ||
| 2024-03-11 | Kauffman Michael Director | Returned to the company · Stock Option (right to buy) | −2,083 | 0 |
Page 10 of 17 · 326 trades